FDC approves Rs 120 crore buyback of up to 24 lakh shares

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionExceptional ItemResults View source PDF Explain this filing

FDC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+6.8%Reaction day

₹353.00

prior close

₹385.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Pharmaceuticals peers, median of 170sector+0.6%+6.2% vs sector

On the reaction day the stock moved 6.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.8

10m

-4.3

15m

-4.2

30m

-3.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+6.8pendingpending+0.6+6.2

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

FDC's board approved a proportional tender offer to buy back up to 2.4 million shares at Rs 500 each, for up to Rs 120 crore and covering 1.47% of paid-up capital. The record date is November 13, 2026, and promoters plan to participate. Consolidated September-quarter revenue rose 21% to Rs 572.14 crore, while profit for FDC shareholders rose 105% to Rs 43.06 crore.

Likely market impact

The buyback may support per-share value and shareholder returns, but the Rs 120 crore cash outlay could reduce financial flexibility.